Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/9865310

Download in:

View as

General Info

PMID
9865310